Obbligazioni perpetue e subordinate Tutto quello che avreste sempre voluto sapere sulle obbligazioni perpetue... - Cap. 3
- Creatore Discussione Joe Silver
- Data di Inizio
apaci2
Ad bestias
A livelli pratici è effettivamente quello che è successo.
Qui dovunque si trova EU o qualsiasi cosa faccia conta poco, siamo e rimaniamo S&P centrici.
Certo che questa volta mi pare esagerato. Magari oggi facciamo +4% eh eh eh
russiabond
Il mito, la leggenda.
ortinn
Banned
cris71
Forumer storico
Raiffeisen bank int.
Posto 2 notizie su Raiffeisen bank:
http://www.investmentview.com/thoms...tory&rowCountSidebar=0&docKey=315-L5N16I2IU-1
Leggendo l'articolo ne ho tratto l'impressione che la la soluzione della questione relativa alla vendita filiale polacca di Raiffeisen sia molto lontana purtroppo
La seconda riguarda la fusione di 4 società assicurative ( Uniqa, Raiffeisen Versicherung, Salzburger Landes-Versicherung und FinanceLife Lebensversicherrung) in 1
en/wirtschaft/Aus-vier-mach-eins-Raiffeisen-Tochter-Uniqa-raeumt-im-Konzern-auf;art15,2174034#ref=rss
http://www.investmentview.com/thoms...tory&rowCountSidebar=0&docKey=315-L5N16I2IU-1
Leggendo l'articolo ne ho tratto l'impressione che la la soluzione della questione relativa alla vendita filiale polacca di Raiffeisen sia molto lontana purtroppo
La seconda riguarda la fusione di 4 società assicurative ( Uniqa, Raiffeisen Versicherung, Salzburger Landes-Versicherung und FinanceLife Lebensversicherrung) in 1
en/wirtschaft/Aus-vier-mach-eins-Raiffeisen-Tochter-Uniqa-raeumt-im-Konzern-auf;art15,2174034#ref=rss
angy2008
Forumer storico
va bene che quelli comprano a macchia di leopardo ma su BIM potrebbe essere un buon investimento a basso costo se riescono poi a portarla in utile espandendone il business mentre sulla Veneto l'esborso è più alto e lo sviluppo di una banca a carattere locale sarebbe più complicato...magari fanno un offerta completa ...post adk 2 X 1
Myskin
Forumer stoico
11/03/2016
VIVAT Annual Results 2015
Strategic Review on Track
Return to profit in 2015
Profit for 2015 at € 109 million (2014: loss of € 612 million)
Increase in net underlying result for 2015 to € 33 million (2014: € 0 million)
Strong capital position following € 1.35 billion capital injection by new shareholder Anbang reflected in Solvency I ratio of 240% at 31 December 2015
Solvency II ratio at year-end 2015 estimated to be approximately 160% • Commercial performance remains a challenge
VIVAT concluded strategic review; focus on innovation to improve customer experience, reduce complexity and cut costs
Statement of the Executive Board
“2015 was an impactful year for VIVAT. Its acquisition by Anbang marked the end of a challenging period for VIVAT following the nationalisation of SNS REAAL, its former shareholder. With Anbang’s support, as shown by the EUR 1.35 billion capital injection, VIVAT now has the opportunity to transform its business, allowing it to become an agile leading insurer in the Netherlands. Following substantial losses in both 2013 and 2014, VIVAT returned to profit in 2015, both on a net and an underlying basis. Due to the persistently challenging market, premium income remained under pressure. In order to maintain and increase its profitability on a structural basis, VIVAT concluded a strategic review to transform its organisation. VIVAT will increase its focus on customers, offering innovative products and sophisticated digital solutions. To create an agile organisation, VIVAT will simplify its governance structure and reduce the complexity of the organisation. With these plans, we expect to be able to achieve considerable cost savings. Our shareholder actively supports this transformation.”
http://www.vivatverzekeringen.nl/Media/Default/PDF%20persbericht%20-%20press%20release/160311%20Press%20Release%20VIVAT%20Annual%20Result%202015_def.pdf
VIVAT Annual Results 2015
Strategic Review on Track
Return to profit in 2015
Profit for 2015 at € 109 million (2014: loss of € 612 million)
Increase in net underlying result for 2015 to € 33 million (2014: € 0 million)
Strong capital position following € 1.35 billion capital injection by new shareholder Anbang reflected in Solvency I ratio of 240% at 31 December 2015
Solvency II ratio at year-end 2015 estimated to be approximately 160% • Commercial performance remains a challenge
VIVAT concluded strategic review; focus on innovation to improve customer experience, reduce complexity and cut costs
Statement of the Executive Board
“2015 was an impactful year for VIVAT. Its acquisition by Anbang marked the end of a challenging period for VIVAT following the nationalisation of SNS REAAL, its former shareholder. With Anbang’s support, as shown by the EUR 1.35 billion capital injection, VIVAT now has the opportunity to transform its business, allowing it to become an agile leading insurer in the Netherlands. Following substantial losses in both 2013 and 2014, VIVAT returned to profit in 2015, both on a net and an underlying basis. Due to the persistently challenging market, premium income remained under pressure. In order to maintain and increase its profitability on a structural basis, VIVAT concluded a strategic review to transform its organisation. VIVAT will increase its focus on customers, offering innovative products and sophisticated digital solutions. To create an agile organisation, VIVAT will simplify its governance structure and reduce the complexity of the organisation. With these plans, we expect to be able to achieve considerable cost savings. Our shareholder actively supports this transformation.”
http://www.vivatverzekeringen.nl/Media/Default/PDF%20persbericht%20-%20press%20release/160311%20Press%20Release%20VIVAT%20Annual%20Result%202015_def.pdf
russiabond
Il mito, la leggenda.
...dipende sempre dal prezzo che si paga...
...aspettiamo post quotazione e vediamo chi è dentro...circa 40 giorni